Journal article
Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial
Abstract
Aims: This study aimed to compare the effects of the combination of rivaroxaban and aspirin with aspirin alone on health-related quality of life in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial.
Methods and results: Health-related quality of life assessed using the EQ-5D-3L. The treatment effects on health utility and EQ visual analogue scale (EQ VAS) scores were compared between rivaroxaban plus …
Authors
Xie F; Yan J; Eikelboom J; Anand S; Muehlhofer E; Pullenayegum E; Wang Y; Avezum A; Bhatt DL; Yusuf S
Journal
European Heart Journal Open, Vol. 4, No. 5,
Publisher
Oxford University Press (OUP)
Publication Date
August 31, 2024
DOI
10.1093/ehjopen/oeae083
ISSN
2752-4191